Barclays Maintains Overweight on Hinge Health, Raises Price Target to $110

Barclays analyst Saket Kalia has maintained an Overweight rating on Hinge Health (NYSE: HNGE) and increased the price target from $100 to $110. This adjustment reflects a positive outlook on the company's performance.